GSK
2 stories
-
healthGSK Taps Local Giant SBP to Market Hepatitis B Drug in China
GSK partners with Sino Biopharmaceutical subsidiary CTTQ to sell its experimental chronic hepatitis B therapy bepirovirsen across China.
-
healthAntimicrobial Resistance Crisis: Drug Pipeline Shrinks as Infections Rise
A new report reveals a critical decline in the development of new antibiotics, while drug-resistant infections continue to surge globally.